| |
|
|
| Name: |
ORBIMED ADVISORS LLC |
| City: |
NEW YORK |
| State: |
NY |
| Zip: |
10017 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
23 |
|
View All Holdings |
Currently
Viewing:
Increased Positions |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
EWTX |
Edgewise Therapeutics, Inc. |
3 |
- |
$0.00 |
$273,996,000 |
15,021,721 |
5.03% |
114,631,000 |
454,545 |
16.28 |
N/A |
|
|
BIIB |
Biogen Idec Inc |
6 |
- |
$230.57 |
$194,261,000 |
900,900 |
3.57% |
-19,897,000 |
73,300 |
0.585 |
Biotechnology |
|
|
MRK |
Merck & Co Inc |
7 |
- |
$131.20 |
$173,646,000 |
1,316,000 |
3.19% |
58,630,000 |
261,000 |
0.052 |
Drug Manufacturers - ... |
|
|
JANX |
Janux Therapeutics, Inc. |
8 |
- |
$0.00 |
$160,975,000 |
4,275,553 |
2.96% |
125,374,000 |
957,626 |
10.716 |
N/A |
|
|
ALPN |
Alpine Immune Sciences Inc |
12 |
- |
$64.97 |
$106,255,000 |
2,680,496 |
1.95% |
57,933,000 |
145,251 |
4.09 |
N/A |
|
|
ANTM |
Anthem Inc |
18 |
- |
$547.71 |
$87,167,000 |
168,100 |
1.6% |
20,441,000 |
26,600 |
0.067 |
N/A |
|
|
APLS |
Apellis Pharmaceuticals Inc |
25 |
- |
$41.31 |
$76,285,000 |
1,297,800 |
1.4% |
21,082,000 |
375,600 |
1.134 |
N/A |
|
|
ARGX |
Argenx Se |
29 |
- |
$365.81 |
$59,688,000 |
151,600 |
1.1% |
27,504,000 |
67,000 |
0.322 |
N/A |
|
|
ICLR |
ICON plc (ADR) |
30 |
- |
$314.72 |
$58,489,000 |
174,100 |
1.07% |
21,067,000 |
41,900 |
0.219 |
Research Services |
|
|
SIBN |
Si-Bone, Inc. |
36 |
- |
$0.00 |
$51,967,000 |
3,174,521 |
0.95% |
3,847,000 |
881,990 |
7.836 |
N/A |
|
|
GERN |
Geron Corporation |
43 |
- |
$3.81 |
$42,549,000 |
12,893,611 |
0.78% |
41,526,000 |
12,408,611 |
2.374 |
Drug Manufacturers - ... |
|
|
RYTM |
Rhythm Pharmaceuticals, Inc. |
48 |
- |
$37.96 |
$30,541,000 |
704,842 |
0.56% |
5,872,000 |
168,200 |
0.994 |
N/A |
|
|
HRTX |
Heron Therapeutics Inc |
52 |
- |
$3.20 |
$28,009,000 |
10,111,550 |
0.51% |
17,930,000 |
4,182,959 |
8.514 |
Synthetics |
|
|
ACET |
Adicet Bio, Inc |
55 |
- |
$1.60 |
$26,901,000 |
11,447,140 |
0.49% |
11,172,000 |
3,125,000 |
26.714 |
N/A |
|
|
REGN |
Regeneron Pharmaceuticals Inc |
59 |
- |
$982.29 |
$21,945,000 |
22,800 |
0.4% |
10,088,000 |
9,300 |
0.022 |
Biotechnology |
|
|
ARWR |
Arrowhead Pharmaceuticals Inc |
61 |
- |
$24.77 |
$21,154,000 |
739,651 |
0.39% |
11,373,000 |
420,000 |
0.723 |
Business Services |
|
|
MORF |
Morphic Holding, Inc. |
64 |
- |
$29.23 |
$19,659,000 |
558,500 |
0.36% |
11,763,000 |
285,100 |
1.123 |
N/A |
|
|
DXCM |
DexCom Inc |
65 |
- |
$131.36 |
$19,460,000 |
140,300 |
0.36% |
10,377,000 |
67,100 |
0.036 |
Medical Instruments &... |
|
|
IMTX |
Immatics N.V |
67 |
- |
$10.96 |
$18,600,000 |
1,769,708 |
0.34% |
2,348,000 |
226,301 |
2.813 |
N/A |
|
|
VTYX |
Ventyx Biosciences, Inc. |
78 |
- |
$4.73 |
$10,288,000 |
1,870,456 |
0.19% |
10,288,000 |
1,870,456 |
3.719 |
N/A |
|
|
FATE |
Fate Therapeutics Inc |
79 |
- |
$3.90 |
$9,948,000 |
1,355,352 |
0.18% |
7,973,000 |
827,272 |
1.144 |
Biotechnology |
|
|
TXG |
10x Genomics, Inc. |
85 |
- |
$0.00 |
$8,452,000 |
225,200 |
0.16% |
6,225,000 |
185,400 |
0.214 |
N/A |
|
|
VIR |
Vir Biotechnology, Inc. |
91 |
- |
$0.00 |
$6,483,000 |
640,000 |
0.12% |
5,467,000 |
539,000 |
0.502 |
N/A |
|
